1. Home
  2. CTKB vs METCB Comparison

CTKB vs METCB Comparison

Compare CTKB & METCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • METCB
  • Stock Information
  • Founded
  • CTKB 1990
  • METCB 2015
  • Country
  • CTKB United States
  • METCB United States
  • Employees
  • CTKB N/A
  • METCB N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • METCB Coal Mining
  • Sector
  • CTKB Health Care
  • METCB Energy
  • Exchange
  • CTKB Nasdaq
  • METCB Nasdaq
  • Market Cap
  • CTKB 708.8M
  • METCB 571.7M
  • IPO Year
  • CTKB 2021
  • METCB N/A
  • Fundamental
  • Price
  • CTKB $6.46
  • METCB $9.86
  • Analyst Decision
  • CTKB Strong Buy
  • METCB Strong Buy
  • Analyst Count
  • CTKB 3
  • METCB 3
  • Target Price
  • CTKB $9.17
  • METCB $19.67
  • AVG Volume (30 Days)
  • CTKB 892.8K
  • METCB 21.3K
  • Earning Date
  • CTKB 11-05-2024
  • METCB 11-04-2024
  • Dividend Yield
  • CTKB N/A
  • METCB 9.00%
  • EPS Growth
  • CTKB N/A
  • METCB N/A
  • EPS
  • CTKB N/A
  • METCB 0.71
  • Revenue
  • CTKB $201,210,000.00
  • METCB $698,132,000.00
  • Revenue This Year
  • CTKB $7.85
  • METCB N/A
  • Revenue Next Year
  • CTKB $14.82
  • METCB $25.55
  • P/E Ratio
  • CTKB N/A
  • METCB $18.48
  • Revenue Growth
  • CTKB 9.88
  • METCB 11.52
  • 52 Week Low
  • CTKB $4.66
  • METCB $9.42
  • 52 Week High
  • CTKB $9.87
  • METCB $16.77
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 58.79
  • METCB 39.37
  • Support Level
  • CTKB $5.68
  • METCB $10.52
  • Resistance Level
  • CTKB $7.26
  • METCB $10.98
  • Average True Range (ATR)
  • CTKB 0.47
  • METCB 0.55
  • MACD
  • CTKB -0.03
  • METCB -0.07
  • Stochastic Oscillator
  • CTKB 53.94
  • METCB 14.15

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves and resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mill and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: